PROKIDNEY CORP. (PROK) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Low Risk
Limited dilution potential
Last updated: March 18, 2026

Risk Assessment Details

Potential Dilution: 17.62% of current shares
Recent Dilution: 7.38% (2 years)
Historical Dilution Factor: minimal recent dilution
Outstanding Shares
130M
Potential Supply
24M
Additional shares possible
Splits
None
Past 2 years

Summary

PROK currently has 134M outstanding shares. with limited dilution risk as only 23.6M additional shares (17.6%) are authorized for issuance. The company has minimally diluted shareholders by 7.38% over the past 2 years.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Mar 18, 2026

10-K filing | 133.9M shares outstanding

130M 24M
Nov 10, 2025

10-Q filing | 135.0M shares outstanding

130M 24M
Aug 12, 2025

10-Q filing | 130.7M shares outstanding

130M 24M
Jul 07, 2025

POS AM filing: ProKidney Corp. is filing a POS AM to issue up to $500,000,000 of any combination of Class A common stock, preferred stock, and debt securities from time to time at prices and on terms to be determined at or prior to the time of the offering.

130M 24M
May 12, 2025

10-Q filing | 129.0M shares outstanding

130M 24M
Mar 17, 2025

10-K filing | 129.5M shares outstanding

130M 24M
Nov 12, 2024

10-Q filing | 126.2M shares outstanding

130M 24M
Aug 09, 2024

10-Q filing | 126.1M shares outstanding

130M 24M
May 10, 2024

10-Q filing | 61.0M shares outstanding

61M 24M
Mar 22, 2024

10-K filing | 61.7M shares outstanding

62M 24M
Nov 22, 2023

S-3 filing: ProKidney Corp. files an S-3 form to offer up to $500,000,000 of Class A ordinary shares, preference shares and debt securities from time to time.

62M 24M
Nov 14, 2023

10-Q filing | 61.6M shares outstanding

62M 24M
Aug 18, 2023

POS AM filing: This is a POS AM filing for the resale of Class A ordinary shares by selling securityholders.

65M 24M
Aug 10, 2023

10-Q filing | 64.6M shares outstanding

65M 24M
May 11, 2023

10-Q filing | 61.5M shares outstanding

62M 24M
Apr 17, 2023

POS AM filing: This POS AM filing relates to the resale of Class A ordinary shares by selling securityholders of ProKidney Corp.

62M 24M
Mar 28, 2023

10-K filing | 61.5M shares outstanding

62M 260M
Nov 14, 2022

10-Q filing | 61.5M shares outstanding

62M 260M
Aug 26, 2022

S-1/A filing: This S-1/A filing pertains to the resale of Class A ordinary shares by selling securityholders, including PIPE shares, shares issued or issuable pursuant to restricted stock units, and shares issued or issuable pursuant to the Exchange Agreement. The company will not receive any proceeds from the sale of these shares.

62M 260M
Aug 12, 2022

10-Q filing | 61.5M shares outstanding

62M 260M
Aug 09, 2022

S-1 filing: This S-1 filing relates to the resale of Class A ordinary shares by selling securityholders, including PIPE shares, shares from restricted stock units, and shares from the Exchange Agreement. The company will not receive any proceeds from the sale of these shares.

26M 260M
May 16, 2022

10-Q filing | 25.6M shares outstanding

26M 24M
Mar 24, 2022

10-K filing | 25.6M shares outstanding

26M 24M
Nov 15, 2021

10-Q filing | 25.6M shares outstanding

26M 24M
Aug 16, 2021

10-Q filing | 25.6M shares outstanding

26M 24M
Jun 25, 2021

S-1/A filing: Social Capital Suvretta Holdings Corp. III is offering 20,000,000 Class A ordinary shares at $10.00 per share in an initial public offering.

5.8M 24M
Jun 09, 2021

S-1/A filing: Social Capital Suvretta Holdings Corp. III is offering 20,000,000 Class A ordinary shares at $10.00 per share in an initial public offering.

5.8M 24M
Jun 02, 2021

S-1 filing: Social Capital Suvretta Holdings Corp. III is offering 20,000,000 Class A ordinary shares at $10.00 per share in an initial public offering.

5.8M 21M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime